Clinical trial
Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat…
NCT00454519 · Wuhan University, Other · Unknown status
Key facts
| NCT number | NCT00454519 |
|---|---|
| Title | Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis |
| Official title | Cytoreductive Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy for the Treatment of Peritoneal Carcinomatosis From Gastrointestinal Cancer: an Open Label, Randomized, Prospective, Phase 2 Clinical Trial |
| Acronym | IPHC |
| Lead sponsor | Wuhan University, Other |
| Collaborators | NPO Organization to Support Peritoneal Dissemination Treatment Kishiwada Tokushukai Hospital Kusatsu General Hopital Ikeda Hospital |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stomach Neoplasms, Colorectal Neoplasms, Neoplasm Metastasis, Mesothelioma |
| Intervention type | Procedure |
| Interventions | cytoreductive surgery, intraoperative peritoneal hyperthermic chemotherapy with cisplatin and mitomycin |
| Enrollment | 60 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2009 |
| First posted | Mar 30, 2007 |
| Last update posted | Feb 13, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: